These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

983 related items for PubMed ID: 15665303

  • 21. Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IkappaB kinase/nuclear factor-kappaB pathway.
    Ciucci A, Gianferretti P, Piva R, Guyot T, Snape TJ, Roberts SM, Santoro MG.
    Mol Pharmacol; 2006 Nov; 70(5):1812-21. PubMed ID: 16908599
    [Abstract] [Full Text] [Related]

  • 22. Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells.
    Ling MT, Wang X, Ouyang XS, Xu K, Tsao SW, Wong YC.
    Oncogene; 2003 Jul 17; 22(29):4498-508. PubMed ID: 12881706
    [Abstract] [Full Text] [Related]

  • 23. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
    Takada Y, Ichikawa H, Pataer A, Swisher S, Aggarwal BB.
    Oncogene; 2007 Feb 22; 26(8):1201-12. PubMed ID: 16924232
    [Abstract] [Full Text] [Related]

  • 24. Acquired resistance to rituximab is associated with chemotherapy resistance resulting from decreased Bax and Bak expression.
    Olejniczak SH, Hernandez-Ilizaliturri FJ, Clements JL, Czuczman MS.
    Clin Cancer Res; 2008 Mar 01; 14(5):1550-60. PubMed ID: 18316580
    [Abstract] [Full Text] [Related]

  • 25. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis.
    Pandey MK, Sung B, Kunnumakkara AB, Sethi G, Chaturvedi MM, Aggarwal BB.
    Cancer Res; 2008 Jul 01; 68(13):5370-9. PubMed ID: 18593939
    [Abstract] [Full Text] [Related]

  • 26. Eriocalyxin B induces apoptosis in lymphoma cells through multiple cellular signaling pathways.
    Zhang YW, Jiang XX, Chen QS, Shi WY, Wang L, Sun HD, Shen ZX, Chen Z, Chen SJ, Zhao WL.
    Exp Hematol; 2010 Mar 01; 38(3):191-201. PubMed ID: 20045442
    [Abstract] [Full Text] [Related]

  • 27. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
    Cavin LG, Wang F, Factor VM, Kaur S, Venkatraman M, Thorgeirsson SS, Arsura M.
    Mol Cancer Res; 2005 Jul 01; 3(7):403-12. PubMed ID: 16046551
    [Abstract] [Full Text] [Related]

  • 28. Rho/Rhotekin-mediated NF-kappaB activation confers resistance to apoptosis.
    Liu CA, Wang MJ, Chi CW, Wu CW, Chen JY.
    Oncogene; 2004 Nov 18; 23(54):8731-42. PubMed ID: 15480428
    [Abstract] [Full Text] [Related]

  • 29. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
    Tse AK, Wan CK, Shen XL, Yang M, Fong WF.
    Biochem Pharmacol; 2005 Nov 15; 70(10):1443-57. PubMed ID: 16181613
    [Abstract] [Full Text] [Related]

  • 30. NF-kappaB protects Behçet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins.
    Todaro M, Zerilli M, Triolo G, Iovino F, Patti M, Accardo-Palumbo A, di Gaudio F, Turco MC, Petrella A, de Maria R, Stassi G.
    Arthritis Rheum; 2005 Jul 15; 52(7):2179-91. PubMed ID: 15986355
    [Abstract] [Full Text] [Related]

  • 31. Role of Rel/NF-kappaB transcription factors in apoptosis of human hepatocellular carcinoma cells.
    Chiao PJ, Na R, Niu J, Sclabas GM, Dong Q, Curley SA.
    Cancer; 2002 Oct 15; 95(8):1696-705. PubMed ID: 12365017
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of IkappaB kinase subunit 2 in cutaneous T-cell lymphoma down-regulates nuclear factor-kappaB constitutive activation, induces cell death, and potentiates the apoptotic response to antineoplastic chemotherapeutic agents.
    Sors A, Jean-Louis F, Bégué E, Parmentier L, Dubertret L, Dreano M, Courtois G, Bachelez H, Michel L.
    Clin Cancer Res; 2008 Feb 01; 14(3):901-11. PubMed ID: 18245554
    [Abstract] [Full Text] [Related]

  • 33. Activation of PI3K/Akt/IKK-alpha/NF-kappaB signaling pathway is required for the apoptosis-evasion in human salivary adenoid cystic carcinoma: its inhibition by quercetin.
    Sun ZJ, Chen G, Hu X, Zhang W, Liu Y, Zhu LX, Zhou Q, Zhao YF.
    Apoptosis; 2010 Jul 01; 15(7):850-63. PubMed ID: 20386985
    [Abstract] [Full Text] [Related]

  • 34. Diosgenin inhibits osteoclastogenesis, invasion, and proliferation through the downregulation of Akt, I kappa B kinase activation and NF-kappa B-regulated gene expression.
    Shishodia S, Aggarwal BB.
    Oncogene; 2006 Mar 09; 25(10):1463-73. PubMed ID: 16331273
    [Abstract] [Full Text] [Related]

  • 35. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation.
    Tse AK, Wan CK, Zhu GY, Shen XL, Cheung HY, Yang M, Fong WF.
    Mol Immunol; 2007 Apr 09; 44(10):2647-58. PubMed ID: 17240450
    [Abstract] [Full Text] [Related]

  • 36. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A, Richon C, Meslin F, Faure F, Kauffmann A, Lecluse Y, Jalil A, Larue L, Avril MF, Chouaib S, Mehrpour M.
    Oncogene; 2006 Dec 07; 25(58):7618-34. PubMed ID: 16983347
    [Abstract] [Full Text] [Related]

  • 37. Rituximab inhibits the constitutively activated PI3K-Akt pathway in B-NHL cell lines: involvement in chemosensitization to drug-induced apoptosis.
    Suzuki E, Umezawa K, Bonavida B.
    Oncogene; 2007 Sep 13; 26(42):6184-93. PubMed ID: 17420722
    [Abstract] [Full Text] [Related]

  • 38. Rituximab-induced inhibition of YY1 and Bcl-xL expression in Ramos non-Hodgkin's lymphoma cell line via inhibition of NF-kappa B activity: role of YY1 and Bcl-xL in Fas resistance and chemoresistance, respectively.
    Vega MI, Jazirehi AR, Huerta-Yepez S, Bonavida B.
    J Immunol; 2005 Aug 15; 175(4):2174-83. PubMed ID: 16081784
    [Abstract] [Full Text] [Related]

  • 39. Rituximab (anti-CD20) selectively modifies Bcl-xL and apoptosis protease activating factor-1 (Apaf-1) expression and sensitizes human non-Hodgkin's lymphoma B cell lines to paclitaxel-induced apoptosis.
    Jazirehi AR, Gan XH, De Vos S, Emmanouilides C, Bonavida B.
    Mol Cancer Ther; 2003 Nov 15; 2(11):1183-93. PubMed ID: 14617792
    [Abstract] [Full Text] [Related]

  • 40. Blockage of interleukin-6 signaling with 6-amino-4-quinazoline synergistically induces the inhibitory effect of bortezomib in human U266 cells.
    Park J, Ahn KS, Bae EK, Kim BS, Kim BK, Lee YY, Yoon SS.
    Anticancer Drugs; 2008 Sep 15; 19(8):777-82. PubMed ID: 18690088
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 50.